Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
EV/Net Sales

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

OXYGENTA PHARMACEUTICAL Last 5 Year EV/Net Sales History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 3.263.893.871.421.11

What is the latest EV/Net Sales ratio of OXYGENTA PHARMACEUTICAL ?

The latest EV/Net Sales ratio of OXYGENTA PHARMACEUTICAL is 3.26 based on Mar2025 Standalone results.
Year EV/Net Sales
Mar20253.26
Mar20243.89
Mar20233.87
Mar20221.42
Mar20211.11

How is EV/Net Sales of OXYGENTA PHARMACEUTICAL Trending?

Years EV/Net Sales % Change
Mar2025 3.26
-16.20
Mar2024 3.89
0.52
Mar2023 3.87
172.54
Mar2022 1.42
27.93
Mar2021 1.11 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare EV/Net Sales ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹179.5 Cr -3.3% -6.9% -40.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,470.0 Cr -0.3% 3.1% 2.2% Stock Analytics
DIVIS LABORATORIES ₹161,996.0 Cr 0.5% -2.9% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,440.0 Cr 0.1% 1.4% 37.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,417.0 Cr 1.9% 1.4% 10.7% Stock Analytics
CIPLA ₹101,445.0 Cr -3.3% -6.9% -17% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-3.3%

-6.9%

-40.9%

SENSEX

-0%

-10.7%

1%


You may also like the below Video Courses